Lavecaps

Lavender oil, the active ingredient in Lavecaps, is a herbal presented as an oral preparation for oral use. It is traditionally employed to support relaxation and mild discomfort. GNH USA supplies Lavecaps as a licensed, GDP-compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Lavecaps, containing lavender oil, is used in the context of mild nervous system and digestive support.

- Mild anxiety: may promote a sense of calm and relaxation. - Sleep disturbances: may help facilitate the onset of restful sleep. - Digestive discomfort: may aid in easing occasional stomach upset.

Adverse reactions to oral lavender oil are generally uncommon but can occur.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Allergic skin reaction: rash or itching after ingestion. - Taste disturbance: unusual after‑taste perception.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic response requiring immediate medical attention. - Liver enzyme elevation: rare hepatic involvement. - Seizure activity: extremely rare, reported in susceptible individuals. - Severe respiratory depression: very uncommon, usually in combination with other CNS depressants. - Persistent vomiting: may lead to dehydration if untreated.

When considering oral lavender oil, several safety points should be observed. - Pregnancy: safety not established; use only if clearly needed and under medical advice. - Breastfeeding: caution advised due to limited data on infant exposure. - Known allergy: avoid if hypersensitivity to lavender or related plants is documented. - Concomitant CNS depressants: monitor for additive sedative effects. - Pediatric use: restrict to older children and only under professional supervision. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lavender oil may interact with certain medications; awareness of the interaction level is important.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Central nervous system depressants (e.g., benzodiazepines): may potentiate sedation.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): possible increase in serotonergic activity. - Antihypertensive agents: may cause additive blood‑pressure lowering. - Hormonal contraceptives: occasional reports of reduced efficacy. - Antiplatelet drugs (e.g., aspirin): may modestly enhance antithrombotic effect.